Select a product:
Infectious disease
Bone and mineral metabolism
Endocrinology
Oncology
Liaison ®
Spq protein
Autoimmunity
Therapeutic drug monitoring
Cns
International Catalog
TUMOUR MARKERS - RIA
IRMA-coat® CEA |
324321/100 tubes |
Intended use |
For the immunoradiometric determination of Carcinoembryonic Antigen (CEA) |
Label |
125 I |
Method |
IRMA Coated Tube |
Controls included |
Two levels, lyophilic |
No. standard |
6; 0-100 ng/mL |
Detection limit |
< 0.6 ng/mL |
Incubations |
4 h/RT shaking |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
Radioactivity |
705 kBq - 19 µCi/100 tests |
IRMA-mat® AFP |
324471/100 tubes |
Intended use |
For the immunoradiometric determination of Alpha-Fetoprotein (AFP) |
Label |
125 I |
Method |
IRMA Coated Tubes |
Controls included |
One level, lyophilic |
No. standard |
7; 0-600 IU/mL |
Detection limit |
< 2.0 IU/mL (MRC 72/225) |
Incubations |
3 h/RT, shaking |
Sample type |
Serum/Amniotic Fluid |
Sample size |
25 µL |
Radioactivity |
< 424 kBq - 11.5 µCi/100 tests |
Prolifigen® TPA® - M IRMA |
324121/100 beads |
Intended use |
For the monoclonal immunoradiometric determination of Tissue-Polypeptide Antigen (TPA®) |
Label |
125 I |
Method |
IRMA, Coated Beads |
Controls included |
Two levels |
No. standard |
8 ; 0-4000 U/L |
Detection limit |
< 15 U/L |
Incubations |
2h/RT shaking |
Sample type |
Serum |
Sample size |
100 µL |
Radioactivity |
< 1000 kBq - 27 µCi/100 tests |
CA19-9™ IRMA |
R0055/50 tubes |
Intended use |
For the immunoradiometric determination of 1116NS-19-9 defined Antigen (CA 19-9™) |
Label |
125 I |
Method |
IRMA Coated Tubes |
Controls included |
One level, lyophilic |
No. standard |
6; 0-240 U/mL |
Detection limit |
< 3 U/mL |
Incubations |
2 h/RT, shaking |
Sample type |
Serum |
Sample size |
100 µL |
Radioactivity |
129 kBq - 3.5 µCi/50 tests |
CA125II® IRMA |
R0053/50 tubes |
Intended use |
For the immunoradiometric determination of OC 125 defined Antigen (CA 125II®) |
Label |
125 I |
Method |
IRMA Coated Tubes |
Controls included |
One level, lyophilic |
No. standard |
6; 0-500 U/mL |
Detection limit |
< 1 U/mL |
Incubations |
3 h/RT shaking |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
Radioactivity |
185 kBq - 5 µCi/50 tests |
CA 15-3™ IRMA |
R0054/50 tubes |
Intended use |
For the immunoradiometric determination of DF3 defined Antigen (CA 15-3™) |
Label |
125 I |
Method |
IRMA Coated Tubes |
Controls included |
One level, lyophilic |
No. standard |
6; 0-300 U/mL |
Detection limit |
< 2.0 U/mL |
Incubations |
2 h/RT shaking |
Sample type |
Serum |
Sample size |
100 µL (1:101) |
Radioactivity |
< 385 kBq - 10 µCi/50 tests |
CA 72-4® IRMA |
R0056/50 tubes |
Intended use |
For the immunoradiometric determination of CA 72-4® defined Antigen (TAG72) |
Label |
125 I |
Method |
IRMA Coated Tubes |
Controls included |
One level, lyophilic |
No. standard |
5; 0-100 U/mL |
Detection limit |
< 2.0 U/mL |
Incubations |
4 h/RT + 18-20 h/2-8°C |
Sample type |
Serum |
Sample size |
100 µL |
Radioactivity |
< 222 kBq - 6 µCi/50 tests |
PSA total IRMA |
R0014/100 Tubes |
Intended use |
For the quantitative determination of total Prostate-Specific Antigen (T-PSA) |
Label |
125 I |
Method |
IRMA Coated Tubes |
No. standard |
5; 0-100 ng/mL |
Detection limit |
0.1 ng/mL |
Incubations |
2 h/RT, shaking |
Feature & benefits |
Monoclonal Antibodies |
Sample type |
Serum/Plasma |
Sample size |
100 µL |
Radioactivity |
580 kBq - 15.7 µCi/100 tests |
PSA free IRMA |
R0015/50 Tubes |
Intended use |
For the quantitative determination of free Prostate-Specific Antigen (f-PSA) |
Label |
125 I |
Method |
IRMA Coated Tubes |
No. standard |
5; 0-30 ng/mL |
Detection limit |
0.02 ng/mL |
Incubations |
2 h/RT, shaking |
Feature & benefits |
Monoclonal Antibodies |
Sample type |
Serum/Plasma |
Sample size |
200 µL |
Comments |
Not available in all countries |
Radioactivity |
275 kBq - 7.4 µCi/50 tests |
Prolifigen® NSE IRMA |
324560/50 beads |
Intended use |
For the immunoradiometric determination of Neuron-specific Enolase (NSE) |
Label |
125 I |
Method |
IRMA, Coated Beads |
Controls included |
Two levels, lyophilic |
No. standard |
6; 0-200 µg/L |
Detection limit |
0.5 µg/L |
Incubations |
3 h/RT |
Sample type |
Serum |
Sample size |
25 µL |
Radioactivity |
< 188 kBq - 5.1 µCi/50 tests |
Prolifigen® TK-REA |
324250/50 Tablets |
Intended use |
For the direct determination of Thymidine Kinase (TK) |
Label |
125 I |
Method |
REA Separator Tablets |
Controls included |
Two levels, lyophilic |
No. standard |
5; 0-80 U/L |
Detection limit |
< 0.6 U/L |
Incubations |
4 h/37°C in water bath |
Sample type |
Serum |
Sample size |
20 µL |
Radioactivity |
< 185 kBq - 5 µCi/50 tests |
IRMA-mat® Ferritin |
324511/100 tubes |
Intended use |
For the immunoradiometric determination of Ferritin |
Label |
125 I |
Method |
IRMA coated tubes |
Controls included |
One level |
No. standard |
7; 0 -1000 ng/mL |
Detection limit |
< 1.0 ng/mL (NIBSC 94/572) |
Incubations |
2h/RT, shaking |
Sample type |
Serum |
Sample size |
25 µL |
Radioactivity |
< 456 kBq - 12.3 µCi/100 tests |


